tyrosine has been researched along with Prosthesis Durability in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Damron, TS; DeBoyace, SD; Ee, JS; Margulies, BS; Parsons, AM; Policastro, CG | 1 |
Anderson, HV; Assali, AR; Fujise, K; Ghani, M; Rosales, OR; Schroth, G; Sdringola, S; Smalling, RW; Westbrook, LA | 1 |
Hetzer, R; Koster, A; Kuppe, H; Loebe, M; Mertzlufft, F | 1 |
3 other study(ies) available for tyrosine and Prosthesis Durability
Article | Year |
---|---|
Functionally deficient mesenchymal stem cells reside in the bone marrow niche with M2-macrophages and amyloid-β protein adjacent to loose total joint implants.
Topics: Aged; Amyloid beta-Protein Precursor; Arthroplasty, Replacement; Bone Marrow; Femur; Humans; Macrophages; Mesenchymal Stem Cells; Middle Aged; Osteogenesis; Prosthesis Failure; Reoperation; tau Proteins; Tyrosine | 2015 |
Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prosthesis Failure; Retrospective Studies; Stents; Time Factors; Tirofiban; Tyrosine | 2000 |
Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant.
Topics: Cardiopulmonary Bypass; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Heparin; Hirudins; Humans; Kidney Function Tests; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Care; Prosthesis Failure; Recombinant Proteins; Reoperation; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |